Important note
This AI stock analysis for Schrodinger is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
Schrodinger - AI Stock Analysis
Analysis generated May 6, 2025
Schrodinger, Inc. is a leader in the field of computational drug discovery and materials science. Founded in 1990, the company specializes in the development and application of advanced computational methods to accelerate the discovery of new therapeutics and materials. With a robust platform that integrates predictive modeling, data analytics, and machine learning, Schrodinger aims to transform the landscape of drug discovery and development, reducing costs and timelines while improving success rates.
Fundamental Analysis
Revenue for the last quarter was $88 million, representing a significant increase of 150.26% compared to the previous quarter and a 19.14% increase year-over-year. This robust revenue growth indicates a strong demand for Schrodinger's products and services, a positive indicator for potential investors.
However, net income for the last quarter was $40 million, a decrease of 5.45% from the previous quarter and a substantial 31.12% decrease year-over-year. This decline raises concerns about the company's profitability and cost management. EBITDA for the same period was $19 million, showing a 71.66% increase from the previous quarter and a 32.97% year-over-year increase, indicating strong operational performance despite the declining net income.
Schrodinger's current Price-to-Earnings (P/E) ratio stands at 46.78, which may be seen as high, suggesting potential overvaluation. In addition, the recent insider selling highlights potential bearish sentiment among those closest to the company's operations.
Technical Analysis
Today's stock price is $24.46, an increase of 35.66% over the last month, showcasing a positive short-term trend. Over a longer term, the stock has grown 3.12% year-over-year, indicating sustained, albeit slower, growth.
However, the current trend appears bearish. The Simple Moving Average (SMA) 10 stands at 25.48, lower than the previous SMA10 of 25.68, suggesting a potential downward trend. Additionally, the Relative Strength Index (RSI) is 21.4, indicating that the stock may be oversold and potentially poised for a bullish reversal.
Alternative Data Analysis
Data from job postings and employee sentiment reveal mixed signals. Schrodinger has 24 open positions, down by 27% over the last couple of months, possibly indicating cost-cutting measures. However, employee sentiment remains high, with 88% of employees maintaining a positive outlook, which has trended up by 6% recently, highlighting internal optimism.
Regarding customer acquisition, Schrodinger's website has garnered an estimated 120,000 visitors, up by 36% recently, a bullish indicator suggesting increased customer interest. Furthermore, the company's Instagram page has 1,500 followers, up by 10%, signaling growing brand engagement.
The AltIndex AI score for Schrodinger is 63, which is interpreted as a buy signal, blending fundamental, technical, and alternative data insights.
Conclusion and Recommendation
In summary, Schrodinger demonstrates robust revenue growth and strong operational performance based on EBITDA, despite some concerns about declining net income and a high P/E ratio. The technical outlook appears mixed, with recent upward price movement juxtaposed against a potentially bearish trend in short-term averages. Alternative data offers optimistic insights, with rising employee and customer engagement metrics.
Given the comprehensive data analysis, it appears that Schrodinger has positive growth potential but faces some profitability and valuation challenges. Potential investors should weigh these factors carefully and consider current market conditions, industry trends, and their risk tolerance before making an investment decision.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.